Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The research helps understand how finasteride works and aids drug development.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

No link found between specific genes and female pattern hair loss.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The extract from Bacillus/Trapa japonica fruit helps increase hair growth and could be a potential treatment for hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Glioblastoma cells can make androgens, which might help the tumor grow.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Et-BB3-CMU rice bran extract may be a promising natural option for promoting hair growth and preventing hair loss.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Genetic variations affect dutasteride treatment response for male pattern hair loss.